05/25/2021
Experts predict the global neurotechnology market will cross $19 billion by the end of 2026 due to its increasingly relevant use cases and astronomical growth opportunity. Though the space’s latest technological innovations have enabled progress for disorders like over-activation, sleep deprivation and depression, and are offering therapeutic value in cases like epilepsy and degenerative motor disorders, much white space remains to be explored. Attraction of the venture capital community toward neurotechnology start-ups over the past few years has resulted in various merger and acquisition activity, driving significant investments and growth. What’s capturing the attention of investors worldwide? What about this market is getting pitches heard? Of the neuro areas ripe for innovation, where is money going next? Tune in to find out.
Moderator:
Akhil Saklecha, MD, Managing Director of Ventures, Cleveland Clinic
Tara Butler, MD, Managing Director, Ascension
Justin Klein, MD, JD, Co-Founder & Managing Partner, Vensana
Gowri Raman, Director, Venture Capital, Medtronic
Elan Tye, Principal, Jazz Ventures